Skip to content
IGIGIG279279279

Drawing based on the label description. No photo yet.

“The 50 mg tablets are yellow, round, biconvex tablets de-bossed with IG on one side and 279 on other”

IG 279 pill

Pill with imprint IG 279 is yellow, round, 7 mm and has been identified as Topiramate 50 mg. It is used for bipolar disorder, focal seizures and tonic-clonic seizures. It is supplied by Aidarex Pharmaceuticals LLC.

Topiramate 50 mg

Imprint
IG 279
Strength
50 mg
Used for
Bipolar disorder, focal seizures and tonic-clonic seizures
Color
Yellow
Shape
Round
Size
7 mm
Score
No score line
Form
Tablet
Manufacturer
Aidarex Pharmaceuticals LLC
NDC
33261-400, 31722-279, 33261-400-02, 33261-400-07, 33261-400-14, 33261-400-28, 33261-400-30, 33261-400-60, 33261-400-90, 31722-279-60, 31722-279-05, 31722-279-10, 50436-9950, 50436-9950-1, 50436-9950-2, 50436-9950-3, 71610-193, 60429-770, 71610-193-53, 61919-172, 61919-172-60, 61919-172-90, 61919-172-72, 63187-228, 63187-228-30, 63187-228-60, 63187-228-90, 71610-486, 76282-279, 71610-486-30, 71610-486-53, 71610-486-60, 71610-486-80, 76282-279-60, 76282-279-10, 69097-817, 69097-817-03, 69097-817-12, 69097-817-15

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Topiramate pills and guides

What is Topiramate used for?

Topiramate is used for bipolar disorder, focal seizures, tonic-clonic seizures and pain.

Official uses from the US prescribing label

Monotherapy Epilepsy

Topiramate Extended-Release Capsules are indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older.

Adjunctive Therapy Epilepsy

Topiramate Extended-Release Capsules are indicated as adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut Syndrome in patients 2 years of age and older.

Migraine

Topiramate Extended-Release Capsules are indicated for the preventive treatment of migraine in patients 12 years of age and older.

From the FDA-approved label on DailyMed (published Oct 01, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows IG and the other side shows 279.
  • It is yellow, round, 7 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Topiramate

Inactive: Lactose Monohydrate, Cellulose, Microcrystalline, Starch, Corn, Sodium Starch Glycolate Type A Potato, Magnesium Stearate, Silicon Dioxide, Hypromellose 2910 (3 Mpa.s), Hypromellose 2910 (6 Mpa.s), Polyethylene Glycol 400, Polysorbate 80, Ferric Oxide Yellow

Also distributed by

Camber Pharmaceuticals, Inc., Unit Dose Services, Aphena Pharma Solutions - Tennessee, LLC, Direct Rx, Proficient Rx LP, Exelan Pharmaceuticals Inc., Cipla USA Inc.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Topiramate pills